Feb. 6, 2003 (New Orleans) — In a head-to-head study comparing intra-articular hylan GF-20 injection (Synvisc) to corticosteroid injection for knee osteoarthritis, "there was no difference in outcome ...

Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...

(Recasts first paragraph; adds Genzyme comments, sales figures, competitors, byline; updates stock price) By Lisa Richwine GAITHERSBURG, Md., Dec 9 (Reuters) - A U.S. advisory panel has unanimously ...

To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...

Genzyme has won a crucial vote by FDA advisers in favor of its single injection form of Synvisc, a therapy that eases knee pain by providing a cushion between joints. The five-member expert panel ...

Genzyme Corp. is challenging a decision by the Centers for Medicare and Medicaid Services to create a single reimbursement code for osteoarthritis treatments that would drop the reimbuirsement rate ...

4. Synvisc knee injections. There was a recent coding change in 2010 for synvisc knee injections with the J7325 code. “This code is to be used for synvisc injections regardless of whether the ...

Sanofi has initiated a U.S. recall of a lot of its injected gel for treating arthritis in knees which has tested positive for microbial contamination and been linked to some adverse events. Sanofi ...